loadpatents
name:-0.11175107955933
name:-0.032559871673584
name:-0.0084719657897949
Elias; Laurence Patent Filings

Elias; Laurence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Elias; Laurence.The latest application filed is for "use of inhibitors of brutons tyrosine kinase (btk)".

Company Profile
5.18.42
  • Elias; Laurence - Berkeley CA
  • Elias; Laurence - Emeryville CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk)
App 20220249494 - Buggy; Joseph J. ;   et al.
2022-08-11
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk)
App 20220175785 - Buggy; Joseph J. ;   et al.
2022-06-09
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk)
App 20210361657 - Buggy; Joseph J. ;   et al.
2021-11-25
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20210269861 - Harley; Calvin B. ;   et al.
2021-09-02
Methods For The Treatment Of Her2 Amplified Cancer
App 20210145835 - Chen; Jun ;   et al.
2021-05-20
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors
App 20200276199 - Buggy; Joseph J. ;   et al.
2020-09-03
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20190382829 - Harley; Calvin B. ;   et al.
2019-12-19
Methods For The Treatment Of Her2 Amplified Cancer
App 20190167687 - Chen; Jun ;   et al.
2019-06-06
Method for identification of sensitivity of a patient to telomerase inhibition therapy
Grant 10,196,677 - Harley , et al. Fe
2019-02-05
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20180280395 - Buggy; Joseph J. ;   et al.
2018-10-04
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20180256581 - Buggy; Joseph J. ;   et al.
2018-09-13
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors
App 20180193345 - Buggy; Joseph J. ;   et al.
2018-07-12
Methods for the treatment of HER2 amplified cancer
Grant 10,016,434 - Chen , et al. July 10, 2
2018-07-10
Use of inhibitors of Bruton's tyrosine kinase (Btk)
Grant 10,016,435 - Buggy , et al. July 10, 2
2018-07-10
Use of inhibitors of Bruton'S tyrosine kinase (Btk)
Grant 10,004,745 - Buggy , et al. June 26, 2
2018-06-26
Use of inhibitors of Bruton's tyrosine kinase (Btk)
Grant 10,004,746 - Buggy , et al. June 26, 2
2018-06-26
Methods For The Treatment Of Her2 Amplified Cancer
App 20180071294 - Chen; Jun ;   et al.
2018-03-15
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20180036313 - Buggy; Joseph J. ;   et al.
2018-02-08
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20180015091 - BUGGY; JOSEPH J. ;   et al.
2018-01-18
Use of inhibitors of bruton'S tyrosine kinase (BTK)
Grant 9,814,721 - Buggy , et al. November 14, 2
2017-11-14
Use of inhibitors of bruton's tyrosine kinase (Btk)
Grant 9,801,883 - Buggy , et al. October 31, 2
2017-10-31
Use of inhibitors of bruton's tyrosine kinase (BTK)
Grant 9,801,881 - Buggy , et al. October 31, 2
2017-10-31
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
Grant 9,795,605 - Buggy , et al. October 24, 2
2017-10-24
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20170298421 - Harley; Calvin B. ;   et al.
2017-10-19
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20170266186 - Buggy; Joseph J. ;   et al.
2017-09-21
Methods for the treatment of HER2 amplified cancer
Grant 9,724,349 - Chen , et al. August 8, 2
2017-08-08
Methods for the Treatment of HER2 Amplified Cancer
App 20170151243 - Chen; Jun ;   et al.
2017-06-01
Method for identification of sensitivity of a patient to telomerase inhibition therapy
Grant 9,617,583 - Harley , et al. April 11, 2
2017-04-11
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20170035762 - Buggy; Joseph J. ;   et al.
2017-02-09
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20160324859 - Buggy; Joseph J. ;   et al.
2016-11-10
Methods for the treatment of HER2 amplified cancer
Grant 9,415,050 - Chen , et al. August 16, 2
2016-08-16
Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
App 20160175312 - Buggy; Joseph J. ;   et al.
2016-06-23
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors
App 20160000792 - BUGGY; Joseph J. ;   et al.
2016-01-07
Use of inhibitors of Bruton's tyrosine kinase (Btk)
Grant 9,125,889 - Buggy , et al. September 8, 2
2015-09-08
Inhibitors of Bruton'S tyrosine kinase for the treatment of solid tumors
Grant 9,107,924 - Buggy , et al. August 18, 2
2015-08-18
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20150152488 - Harley; Calvin B. ;   et al.
2015-06-04
Use of inhibitors of Bruton's tyrosine kinase (Btk)
Grant 8,999,999 - Buggy , et al. April 7, 2
2015-04-07
Methods For The Treatment Of Her2 Amplified Cancer
App 20150044217 - CHEN; Jun ;   et al.
2015-02-12
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20150031710 - BUGGY; Joseph J. ;   et al.
2015-01-29
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20150031711 - Buggy; Joseph J. ;   et al.
2015-01-29
Method for identification of sensitivity of a patient to telomerase inhibition therapy
Grant 8,877,723 - Harley , et al. November 4, 2
2014-11-04
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20140303191 - Buggy; Joseph J. ;   et al.
2014-10-09
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20140194446 - BUGGY; Jospeh J. ;   et al.
2014-07-10
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors
App 20140079690 - BUGGY; Joseph J. ;   et al.
2014-03-20
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20130310402 - Buggy; Joseph J. ;   et al.
2013-11-21
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20130273030 - Buggy; Joseph J. ;   et al.
2013-10-17
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20130202611 - Buggy; Joseph J. ;   et al.
2013-08-08
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20130195852 - Buggy; Joseph J. ;   et al.
2013-08-01
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20120183535 - Buggy; Joseph J. ;   et al.
2012-07-19
The Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20120100138 - Buggy; Joseph J. ;   et al.
2012-04-26
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk)
App 20120087915 - Buggy; Joseph J. ;   et al.
2012-04-12
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20110263685 - Harley; Calvin B. ;   et al.
2011-10-27
Methods for treating renal cell carcinoma
Grant 8,012,465 - Elias , et al. September 6, 2
2011-09-06
Methods for treating renal cell carcinoma
App 20100316595 - Elias; Laurence ;   et al.
2010-12-16
Methods for treating renal cell carcinoma
App 20070014765 - Elias; Laurence ;   et al.
2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed